Skip to content Home / Companies / LLY LLY
ELI LILLY & Co (LLY) S&P 500 XNYS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest LLY Insider Trades
About ELI LILLY & Co (LLY) Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Headquarters INDIANAPOLIS, IN
Employees 50,000
Listed 1970
Exchange XNYS https://www.lilly.com SEC filings for LLY on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 4 16,000 $18.84M Grant or award 12 112.45 Option exercise 2 1,962
LLY Insider Transactions (Form 4) 53 172 Form 4 filings on record, the earliest from Oct 22, 2024, newest first. Filing history page 2 of 3.
Date Insider Transaction Security Shares Price Value Feb 19, 2026 ED Eric Dozier - Officer Gift Common Stock 481
Recent LLY Form 8-K Filings 4
Recent LLY Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 17, 2026 Patrik Jonsson Officer 6,500 $7.64M View on EDGAR Aug 10, 2026 DONALD ZAKROWSKI Officer
LLY Insider Trading - FAQ
What is the latest insider trade for LLY? ELI LILLY & Co (LLY) had 17 insider filings in the last 90 days, with the most recent on 2026-08-18. The full record for LLY runs to 172 Form 4 filings, the earliest from 2024-10-22. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying LLY stock? No insider purchases of LLY were filed in the last 90 days. 9 purchases are on record for this company.
How many insiders are selling LLY stock? 4 insider sales of LLY were filed in the last 90 days, totaling $18.84M.
Where can I see LLY SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks LLY Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow LLY insider buys? Create a free InsiderAlpha account and press Watch on this page to add LLY to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track LLY insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free - Officer
IY Ilya Yuffa - Officer Open-market sale $2.88M
Jun 10, 2026
Market cap $1.05T
P/E ratio 39.40
Dividend yield -
Average volume 2.94M
52 week high $1,292.65
52 week low $712.05
Today's high $1,180.00
Today's low $1,162.93
Open $1,172.66
Volume 2.45M
Previous close $1,176.10
Shares outstanding 891.36M Market cap
$1.05T
50,000 employees
LLY Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 4 sales totaling $18.84M.
Most-Active LLY Insiders - Last 90 Days 10 Tax withholding / forfeiture 1 438.71
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Feb 17, 2026 JL Juan R. Luciano - Director Grant or award Common Stock 15.36 $1,036.05 $16K
Feb 17, 2026 JF J. Erik Fyrwald - Director Grant or award Common Stock 9.57 $1,036.05 $10K
Feb 17, 2026 RA Ralph Alvarez - Director Grant or award Common Stock 11.99 $1,036.05 $12K
Feb 16, 2026 DZ Donald A. Zakrowski - Officer Tax withholding / forfeiture Common Stock 81.55 $1,040.00 $85K
Feb 16, 2026 LM Lucas Montarce - Officer Option exercise Common Stock 368 $0.00 -
Feb 16, 2026 LM Lucas Montarce - Officer Tax withholding / forfeiture Common Stock 159.73 $1,040.00 $166K
Feb 16, 2026 LM Lucas Montarce - Officer Option exercise Restricted Stock Unit 368 $0.00 -
Feb 16, 2026 KC Kenneth L. Custer - Officer Tax withholding / forfeiture Common Stock 91.31 $1,040.00 $95K
Feb 16, 2026 KC Kenneth L. Custer - Officer Option exercise Restricted Stock Unit 207 $0.00 -
Feb 16, 2026 AB Adrienne S. Brown - Officer Tax withholding / forfeiture Common Stock 169.97 $1,040.00 $177K
Feb 16, 2026 AB Adrienne S. Brown - Officer Option exercise Restricted Stock Unit 391 $0.00 -
Feb 9, 2026 DR Diogo Rau - Officer Grant or award Common Stock 4,599 $1,044.67 $4.80M
Feb 9, 2026 IY Ilya Yuffa - Officer Grant or award Common Stock 4,163 $1,044.67 $4.35M
Feb 9, 2026 NV Naarden Jacob van - Officer Grant or award Common Stock 4,866 $1,044.67 $5.08M
Feb 9, 2026 DS Daniel Skovronsky - Officer Grant or award Common Stock 15,548 $1,044.67 $16.24M
Feb 9, 2026 DR David A. Ricks - Officer Grant or award Common Stock 38,914 $1,044.67 $40.65M
Feb 9, 2026 DR Diogo Rau - Officer Grant or award Common Stock 4,432 $1,044.67 $4.63M
Feb 9, 2026 LM Lucas Montarce - Officer Grant or award Common Stock 1,365 $1,044.67 $1.43M
Feb 9, 2026 PJ Patrik Jonsson - Officer Grant or award Common Stock 4,818 $1,044.67 $5.03M
Feb 9, 2026 EH Edgardo Hernandez - Officer Grant or award Common Stock 4,384 $1,044.67 $4.58M
Feb 9, 2026 AH Anat Hakim - Officer Grant or award Common Stock 8,278 $1,044.67 $8.65M
Feb 9, 2026 ED Eric Dozier - Officer Grant or award Common Stock 3,512 $1,044.67 $3.67M
Feb 9, 2026 KC Kenneth L. Custer - Officer Grant or award Common Stock 659.28 $1,044.67 $689K
Feb 9, 2026 AB Adrienne S. Brown - Officer Grant or award Common Stock 1,196 $1,044.67 $1.25M
Feb 1, 2026 IY Ilya Yuffa - Officer Option exercise Common Stock 3,394 $0.00 -
Feb 1, 2026 IY Ilya Yuffa - Officer Tax withholding / forfeiture Common Stock 1,512 $1,037.15 $1.57M
Feb 1, 2026 IY Ilya Yuffa - Officer Option exercise Restricted Stock Unit 3,394 $0.00 -
Feb 1, 2026 DS Daniel Skovronsky - Officer Tax withholding / forfeiture Common Stock 5,641 $1,037.15 $5.85M
Feb 1, 2026 DS Daniel Skovronsky - Officer Option exercise Restricted Stock Unit 12,684 $0.00 -
Feb 1, 2026 NV Naarden Jacob van - Officer Tax withholding / forfeiture Common Stock 1,909 $1,037.15 $1.98M
Feb 1, 2026 NV Naarden Jacob van - Officer Option exercise Restricted Stock Unit 4,108 $0.00 -
Feb 1, 2026 DR David A. Ricks - Officer Option exercise Common Stock 31,932 $0.00 -
Feb 1, 2026 DR David A. Ricks - Officer Tax withholding / forfeiture Common Stock 14,297 $1,037.15 $14.83M
Feb 1, 2026 DR David A. Ricks - Officer Option exercise Restricted Stock Unit 31,932 $0.00 -
Feb 1, 2026 DR Diogo Rau - Officer Option exercise Common Stock 3,752 $0.00 -
Feb 1, 2026 DR Diogo Rau - Officer Tax withholding / forfeiture Common Stock 1,674 $1,037.15 $1.74M
Feb 1, 2026 DR Diogo Rau - Officer Option exercise Restricted Stock Unit 3,752 $0.00 -
Feb 1, 2026 PJ Patrik Jonsson - Officer Option exercise Common Stock 3,930 $0.00 -
Feb 1, 2026 PJ Patrik Jonsson - Officer Tax withholding / forfeiture Common Stock 1,752 $1,037.15 $1.82M
Feb 1, 2026 PJ Patrik Jonsson - Officer Option exercise Restricted Stock Unit 3,930 $0.00 -
Feb 1, 2026 EH Edgardo Hernandez - Officer Tax withholding / forfeiture Common Stock 1,591 $1,037.15 $1.65M
Feb 1, 2026 EH Edgardo Hernandez - Officer Option exercise Restricted Stock Unit 3,572 $0.00 -
$LUCD
Lucid Diagnostics Inc.
$IONS
IONIS PHARMACEUTICALS INC
Patrik Jonsson - OfficerOpen-market sale$7.64M
